Community | December 17, 2011 | 18 comments

Feds To Grant Exclusive Cannabinoid License To Pharma Firm

Image
Anonmaly
You may recall that Toke of the Town columnist Ron Marczyk pointed out that the U.S. federal government, a few years back, took out patents on "cannabinoids as antioxidants and neuroprotectants," even while officially denying that cannabis has any medical value.....

Well, turns out they weren't just holding onto that patent for the fun of it. The latest piece of the puzzle to fall into place is the announcement last month in the Federal Register.

The U.S. federal government's Department of Health and Human Services seems about ready to award exclusive rights to apply marijuana as a medical therapeutic. You read that correctly: "exclusive rights."

Now, I don't think of myself as a conspiracy theorist. But when the federal government keeps taking actions that, even when considered separately but especially when viewed together, all seem to be part of a bigger plan to pave the way for the pharmaceutical industry to bulldoze the cottage medical marijuana industry, I start getting antsy.

"We find it hypocritical and incredible that on the one hand, the U.S. Department of Justice is persecuting cannabis patient associations, asserting that the federal government regards marijuana as having absolutely no medical value, despite overwhelming clinical evidence," said Union of Medical Marijuana Patients director James Shaw. "On the other hand, the Department of Health and Human Services is planning to grant patent rights with possible worldwide application to develop medicine based on cannabis."

"Though UMMP welcomes any potential new research that could come from KannaLife Sciences' federal endorsement, it is highly disconcerting that the contemplated grant is an exclusive one," the organization posted on its website.

​"It is a grave injustice that patient association[s] in California are now facing a coordinated and comprehensive attack by the DOJ, while one pharmaceutical company in New York stands to profit tremendously from the monopolization of medical cannabis thanks to the HHS," UMMP posted.

After years of inaction, it seems they are "contemplating" the grant of an exclusive patent license to practice the invention embodied in its U.S. Patent to a company called KannaLife Sciences, Inc., which has offices in New York.

According to Shaw, "it makes no sense for the government to provide U.S. Patent 6,630,507, which the government owns, to a single company with exclusive rights."

Shaw urged medical marijuana patient associations and patients using cannabis for medicinal reasons to protest this giveaway to one pharmaceutical firm.

Who, exactly, is this "KannaLife Sciences," based at 4 Tradewinds Drive in Bayville, N.Y.?

Here's their Facebook page, on which they proudly shared a link to the Federal Register notice, but as yet haven't responded to this question posted 14 hours ago from a Facebook user: "you guys get exclusive rights to a USD Gov't patent on medical marijuana as they put CA & CO dispensaries out of business?!"

Nor to a comment to that post: "If your company is as socially responsible as you claim to be, you will answer this."

The founder of KannaLife Sciences is one Thoma Kikis, according to AngelList, who apparently also founded Inventlab and something called Ovie Entertainment. Kikis, a designer, filmmaker and entrepreneur, co-produced the film Alps (by Oscar-nominated director Yorgos Lanthimos), produced Darkon (being remade by Brad Pitt's Plan B and distributed by IFC), and was executive producer of It's A Disaster (with Julia Stiles and David Cross).

According to the LinkedIn profile of CEO Dean Petkanas, "KannaLife Sciences, Inc. is a socially responsible, developmental stage phyto-medical/bio-pharmaceutical company that specializes in the research, development, and packaging of pharmacological products derived from botanical sources, including the cannabis taxa."

KannaLife's plan for generating revenue and growth is intended to come from (i.) KannaLife's proprietary branding POS and hermetic packaging systems for the medical marijuana industry; (ii.) KannaLife's branded anti-oxidant and recovery skin care ointments and creams; and (iii.) the development, marketing and sale of KannaLife biopharmaceutical and phyto-pharmaceutical products derived from cannabis for the treatment of patients suffering with neuro-degenerative, neuro-toxic and oxidative stress related diseases and disorders.

The Company's focus on product development was born from the burgeoning market in the United States in the use of traditional healthcare models of treatment, utilizing medicinal marijuana and other APIs found in the genus of the cannabis taxa.

​KannaLife intends to profit from the acquisition, development, marketing and sale of phyto-medical drugs and products derived from cannabinol ("CBN") and cannabidiol ("CBD") compounds as art and parcel to the Company's drug development plan. The disease indications to which the Company intends to target for the development of its products are centered on patients suffering from diseases with neuro-degenerative and/or neuro-toxic profiles.


http://www.tokeofthetown.com/assets_c/2011/12/health-benefits-of-medical-marijua...

http://www.tokeofthetown.com/2011/12/feds_to_grant_exclusive_cannabinoid_license...
  1. groups:
    Community,   Politics,   Culture,   Health,   7 more
  2. tags:
    Criminal Exploitation Of The Medically Needy
  3.     
    |

18 comments // Feds To Grant Exclusive Cannabinoid License To Pharma Firm

  • Incredulous
  • hombre76
    • 0
      hombre76  
    • how the fuck do you grant a patent on something that grows in nature? this is complete BULL SHIT. FUCK you OBAMA and you do nothing democrats. I get nothing from your party or that other piece of shit one. getting redi to just say fuck um all.

    • 5 months ago
  • Incredulous
  • hombre76
  • COMMONSENSEFORCOMMONGOOD_COM
    • +1
      COMMONSENSEFORCOMMONGOOD_COM  
    • We must fight it to the end along with all other United Corporate actions in the name of "our Government"! Shout it out, ( We don't accept it, and we'll rebel to the death against it! ). The government can not do anything that we don't accept them doing. This is our country, and it's way past time to kick corporate ass! And this is precisely what I'll forward to the Whitehouse, if it's no more than a shot across the bow.

    • 5 months ago
  • fingers_drumming
    • +1
      fingers_drumming  
    • It is not the job of the US Government to grant exclusive rights to anybody over anything at all. The Government has put itself in the place of a monopoly creator which ought to be the province of the free enterprise system as an end result of competition and regulated by by the same system's natural checks and balances. Whether an economist would feel that my stance on this is a naive one or not, you have to admit that this maneuver goes a long way to support claims that our supposedly democratic government is actually controlled by the hands of big business whos end is to put an end to all competition and to leave the individual with no alternative choices other than dealing with big business for filling all needs. Where will it end? Enough!

    • 5 months ago
  • Ambill94
    • 0
      Ambill94  
    • this comes as no surprise...back in the day, some of us were having conversations about the fact that as soon as it was obvious that cannabis was going to be legalized, at least for "medical" purposes that it would be big pharma who would got the rights...they would become the exclusive beneficiaries of the graft and corruption they dispense all over our legislative branches...

      Humboldt county CA and a few other places were anomalies...surprised they lasted as long as they did...

      next, the same will eventually happen to the herbal, vitamin and mineral supplement industry...just a matter of time...

      We have to shut this corrupt system down and demonstrate to the world how democracy SHOULD work...

    • 5 months ago
  • NiceN
  • Conniepae
  • Conniepae
    • +2
      Conniepae  
    • Of course our government will sell the patent for a God Made plant to the highest bidder. The sound of money, surpasses the will of the people. Cha-ching in the pocket of corporate America, makes their world go round.

      The corporate world may not have room for us? They care about our money, not our well being. Sadly, people have been sent to prison for using the natural herb, but corporations can make money by distorting the natural herb, turning it into a 'cash cow' for a corporation. Sad, sad, sad!

    • 5 months ago
  • Johnny_Los_Angeles
  • Conniepae
    • 0
      Conniepae  
    • Johnny_Los_Angeles:

      Actually cannabis has not evolved. We as a society have evolved enough to realize, they removed facts about cannabis hemp, from educational material, leading people to believe the madness they were spinning was the truth. When in fact cannabis hemp has been around for thousands of years.

    • 5 months ago
  • Johnny_Los_Angeles
  • Dagum
    • +2
      Dagum  
    • That's what the federal government is all about. Wheeling and dealing special privileges, Picking and choosing winners and losers. A function that use to belong to the free market and competition.

      It doesn't matter who the fed chooses and who it doesn't, because ultimately the real losers are the American people.

    • 5 months ago
  • artemis6
    • 0
      artemis6  
    • )Let me put on my fortune teller's hat now ... OK . Now said corporation will proceed to totally take a good thing and RUIN it , in every way they can , so it will be patentable and profitable and no real good compared to the original herb .

    • 5 months ago
  • Luna2na
  • Luna2na
    • +2
      Luna2na  
    • It appears that total control of everything by way of patenting is part of the new world order. This gives the "rule of law" another layer of exceptionalism for an elite group, and another pathway to incarcerate people should they actually sort of legalize an herb. Sounds a lot like the patenting of individuals' DNA and disavow any obligation to include that individual any rights to their own DNA or the royalties associated with its marketing revenues.

      Let's see... so now you can soon be arrested for having, or growing, an herb and charged with something akin to copyright infringement?

    • 5 months ago
  • Anonmaly
    • +4
      Anonmaly  
    • In addition the Company has developed a unique "blue ocean" approach to participating in the fast growing multi-billion dollar medical marijuana industry in establishing a "Gold Standard" in QA for delivering a consistent and reliable product to the consumer for dispensing medicinal marijuana in hermetically sealed packaging.

      "The prospective exclusive license territory may be worldwide, and the field of use may be limited to:

      "The development and sale of cannabinoid(s) and cannabidiol(s) based therapeutics as antioxidants and neuroprotectants for use as delivery in humans, for the treatment of hepatic encephalopathy, as claimed in the Licensed Patent Rights." [Italics added.]

      Hepatic encephalopathy's effects are due to liver impairment or liver failure, and can range from forgetfulness, confusion and irritability to inverted sleep-waking patterns, tremor, difficulties with coordination and trouble writing. More severe cases result in lethargy, somnolence, and eventually coma. In the intermediate stages, a characteristic jerking of the limbs -- asterixis -- is observed. There is disorientation and amnesia, and "uninhibited behavior" may occur.

      Coma and seizures are found in the most advanced stages of hepatic encephalopathy; cerebral edema (brain swelling) leads to death.

      Now, does the phrase "for the treatment of hepatic encephalopathy" mean the license is limited to that one condition, or is this a broader license to cover more or all medicinal applications of cannabinoids?

      A mid-day Friday email from Toke of the Town to KannaLife got a response from founder Thoma Kikis, who referred me to CEO Dean Petkanas; a follow-up call to Petkanas hadn't yet been returned by late afternoon.

      In the meantime, let's look some more at the language of the Federal Register notice.

      "The technology describes pharmaceutical compositions of cannabinoids that are useful as tissue protectants, such as neuroprotectants and cardioprotectants," the notice reads. "The cannabinoids compounds may be used, for example, in the treatment of acute ischemic neurological insults or chronic neurodegenerative diseases."

      The next paragraph gets really interesting, because it clearly reveals the anti-scientific and even superstitious way our United States government views the psychoactive effects of cannabis. (Please note that there is a real difference between "toxicity" -- which means it's poisonous, and can produce death -- and "psychoactivity," which can mean, in the case of cannabis, that it just changes your mental state.)

      "Nonpsychoactive cannabinoids, such as Cannabidiol (CBD), are particularly advantageous since they avoid toxicity that is encountered with psychoactive cannabinoids at high doses," [italics added], the notice reads.

      See how they just turned "psychoactivity" into "toxicity," folks?

      There you have it, right from the eminently trustworthy United States Government, that same government which has patented the medical use of natural compounds occurring in the cannabis plant: THC is toxic.

      Of course, it's demonstrably not only nontoxic, but is, as DEA Administrative Law Judge Francis L. Young pointed out, "one of the safest therapeutically active substances known to man."

      Should it really surprise anyone to find the federal government telling an outright lie when it comes to marijuana?

      This is, after all, the same government that has been handing out free marijuana for 30 years to patients in the Compassionate Investigative New Drug program, even while claiming cannabis has no medical value and thus classifying it as a Schedule I narcotic.

      According to the notice in the Federal Register, public comments will be accepted through Monday, December 19.

      Comments need to be submitted in writing by Monday, Dec. 19, to:

      Betty B. Tong, Ph.D.
      Senior Licensing and Patenting Manager
      Office of Technology Transfer
      National Institutes of Health
      6011 Executive Boulevard, Suite 325
      Rockville, MD 20852-3804

      Telephone (301) 594-6565 (note that NIH will only accept written comments for consideration)
      Fax (301) 402-0220
      Website http://www.ott.nih.gov/contactus/licensing_and_patenting.aspx
      Email tongb@mail.nih.gov

    • 5 months ago
more from Community:

top videos